Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Fosravuconazole effectively treated a woman's scalp infection without side effects.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Deucravacitinib helped a man regrow hair significantly.

Combining CAF regimen with fufangbanmao capsules improves thyroid cancer treatment outcomes and reduces side effects.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Vitamin A treatment reduced abnormal cell growth and improved skin conditions in rats with tumors.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Deucravacitinib helped a man regrow hair and improve psoriasis.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.